Heparin-induced thrombocytopenia differential diagnosis: Difference between revisions

Jump to navigation Jump to search
Line 7: Line 7:
Diagnosis of [[Heparin-induced thrombocytopenia]] is mainly done with the help of lab tests. A decrease in [[platelet]] count by > 50% typically after 5-10 days of [[heparin]] therapy leads to a diagnosis of [[HIT]]. Thus, it should be differentiated from other causes of thrombocytopenia like  
Diagnosis of [[Heparin-induced thrombocytopenia]] is mainly done with the help of lab tests. A decrease in [[platelet]] count by > 50% typically after 5-10 days of [[heparin]] therapy leads to a diagnosis of [[HIT]]. Thus, it should be differentiated from other causes of thrombocytopenia like  


* Disseminated Intravascular Coagulation
* [[Disseminated Intravascular Coagulation]]
* Thrombotic Thrombocytopenic Purpura
* [[Thrombotic Thrombocytopenic Purpura]]
* Hemolytic-Uremic Syndrome
* [[Hemolytic-Uremic Syndrome]]
* Immune Thrombocytopenic Purpura
* [[Immune Thrombocytopenic Purpura]]
* Drug-Induced Thrombocytopenia  
* [[Drug-Induced Thrombocytopenia]]
* Posttransfusion Thrombocytopenia
* [[Posttransfusion Thrombocytopenia]]
* Systemic Lupus Erythematosus
* [[Systemic Lupus Erythematosus]]


==Reference==
==Reference==

Revision as of 19:47, 4 December 2011

Heparin-induced thrombocytopenia

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Heparin-induced thrombocytopenia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Heparin-induced thrombocytopenia differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Heparin-induced thrombocytopenia differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Heparin-induced thrombocytopenia differential diagnosis

CDC on Heparin-induced thrombocytopenia differential diagnosis

Heparin-induced thrombocytopenia differential diagnosis in the news

Blogs on Heparin-induced thrombocytopenia differential diagnosis

Directions to Hospitals Treating Heparin-induced thrombocytopenia

Risk calculators and risk factors for Heparin-induced thrombocytopenia differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]

Overview

Heparin-induced thrombocytopenia is diagnosed when the platelet count falls by > 50% typically after 5-10 days of heparin therapy. It should be differentiated by other causes of thrombocytopenia like hemolytic uremic syndrome, Thrombotic thrombocytopenia and others.

Differential diagnosis

Diagnosis of Heparin-induced thrombocytopenia is mainly done with the help of lab tests. A decrease in platelet count by > 50% typically after 5-10 days of heparin therapy leads to a diagnosis of HIT. Thus, it should be differentiated from other causes of thrombocytopenia like

Reference